Menu
Washingtoner
  • Home
  • Boeing
  • Technology
  • Aerospace
  • Daryl Guberman
  • Health
  • Non-profit
  • Services
  • ANSI-ANAB
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Instant IP Teams: Bringing Enterprise-Grade Collaboration to IP Protection at the Speed of Thought
  • PlanetAI Nature Space (PNS), certificadora Europea, lanza su plataforma EUDR-PNS Ready basada en IA, satélites y trazabilidad blockchain
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Radarsign™ Awarded Sourcewell Contract Expanding Access to Traffic Safety Solutions
  • MainConcept and NETINT Bring VPU Acceleration to Easy Video API
  • City Of Spokane Partners With Meals On Wheels To Purchase Cooling Fans For Local Seniors, Residents With Disabilities
  • Larry R. Wasion's Jump Gate 2: Teleporter Expands the Time Travel Universe with High-Stakes Action and Ethical Dilemmas
  • Bruce A. Rosenblat Releases A Pocket Full of Change, a Sharp, Thought-Provoking Book on Growth, Perspective, and Personal Change

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Pieter Bouterse Studio Founder to Retire After 40+ Years; Seeks Successor to Continue Legacy
  • #WeAreGreekWarriors Opening Reception Packs the House
  • Tacoma Police Department's CALEA Public Comment Portal
  • Mensa Brings National Board Game Competition to Northern Virginia April 16-19
  • Special Alert! Highly Undervalued Stock: $317M Revenue in 2025 for Telecom Leader IQSTEL, Inc. (N A S D A Q: IQST)
  • Igniting High-Growth Transformation With Launch of XMax AI Subsidiary, Leveraging Global Furniture Dominance to Enter Explosive AI Markets: XMax Inc
  • Acuvance Earns 2026 Great Place to Work® Certification
  • As Global Tensions Rise, Demand Grows for Private Spaces to Process Thoughts and Speak Freely Online
  • Two Porch Fires Displace Eleven Residents in Spokane
  • Cryptsoft demonstrates Hybrid-PQC Authentication Token use for quantum-safe systems and infrastructure
  • Expert Law Attorneys' Top Law Firms to Know: March 2026
  • Cinder Labs Launches AIRA Shield: Purpose-Built AI Security Platform to Combat Shadow AI
  • City of Tacoma to Host In-Person 'P&L Show & Tell' Financial Workshop for Small Businesses on April 21
  • City of Tacoma Implements Strategic Freeze on Hiring and Promotions
  • Spokane Police Officers Rescue Puppy After Thief Abandoned It
  • Green Office Partner Strengthens Global Operations with Mexico-Based DigitalVAAR Partnership
  • P-Wave Classics Announces the Publication of The Female Quixote, Volume I, by Charlotte Lennox
  • Everwild Music Festival Unveils 2026 Schedule: No Overlapping Sets, Longer Performances, and Epic Late-Night Sets!
  • Riggo Production Studio Launches Monthly Content Package for Growing Brands
  • Accelerating into Active Oil Production with over 100 Barrels per day now being produced as Dual-revenue engine begins Generating Cash Flow: $IBG
_catLbl0 _catLbl1

Popular on Washingtoner

  • Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals - 329
  • New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
  • ANAB's Fraud Taints AS9100, ISO 9001, ISO 13485 Certs (2018-Present) – Stop Paying Registrars
  • Conexwest: Shipping Containers Are Powering the Next Generation of Bitcoin Mining Infrastructure
  • Spokane Teacher Arrested For Sex Crimes Against A Child
  • City of Spokane Prepared For Forecasted Winds
  • Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
  • Why Your Dental Practice Ranks on Google But Still Is Not Getting New Patients
  • City of Tacoma Elevates 28-Year South African Sister City Relationship to District-Wide Partnership
  • Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors

Similar on Washingtoner

  • Marcus Boyd Announces Upcoming Children's Book The Royal World of Autism and Expands His Global Advocacy for Autism Awareness
  • Haven Treatment Center to Attend Shared Hope International Training Event in Vancouver
  • #WeAreGreekWarriors Opening Reception Packs the House
  • Igniting High-Growth Transformation With Launch of XMax AI Subsidiary, Leveraging Global Furniture Dominance to Enter Explosive AI Markets: XMax Inc
  • Acuvance Earns 2026 Great Place to Work® Certification
  • Congressional Roundtable Exposes Mental Health Crisis: More Spending and Treatment, Worse Results – CCHR Demands Accountability
  • Dental Implants in Everett, WA: 19th Avenue Dental Offers Permanent Tooth Replacement Solutions
  • Attorney Joseph C. Kreps Files Lawsuit to Stop Alabama State Board of Pharmacy's Unlawful "Revenue-First" Rulemaking
  • Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
  • Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute